Weight loss surgery (WLS) has become accepted as a treatment for obesity and many of its comorbidities. Current indications for WLS require that patients with a body mass index between 35 and 40 kg/m2 suffer from severe comorbid disease in order to attain insurance coverage for surgery. Obesity associated diseases including sleep apnea, diabetes, hypertension, cholelithiasis, thrombophlebitis, and pulmonary embolus may all affect surgical morbidity and mortality. Preoperative Identification of existing comorbidities may be necessary in order to secure access to surgical therapy and enable care givers to intervene in order to optimize outcomes.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Selected Reference
Dixon JB. Surgical treatment for obesity and its impact on NASH. Clin Liver Dis 2007;11:86–101
Gross JB et al. Practice guidelines for the perioperative management of patient with obstructive sleep apnea. Anesthesiology 2006;104:1081–1093
Saltzman E, et al. Criteria for patient selection and multidisciplinary evaluation and treatment of the weight loss surgery patient. Obes Res 2005;13:234–243
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Schneider, B.E. (2008). Identification of Comorbidities and Their Management. In: Nguyen, N.T., De Maria, E.J., Ikramuddin, S., Hutter, M.M. (eds) The SAGES Manual. Springer, New York, NY. https://doi.org/10.1007/978-0-387-69171-8_3
Download citation
DOI: https://doi.org/10.1007/978-0-387-69171-8_3
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-69170-1
Online ISBN: 978-0-387-69171-8
eBook Packages: MedicineMedicine (R0)